CN Patent
CN109310642B — 美沙拉嗪的口服药物组合物
Assigned to Ferring BV · Expires 2021-07-20 · 5y expired
What this patent protects
本文描述了用于口服施用美沙拉嗪的药物组合物,以及制备此类药物组合物的方法,以及使用它们的治疗方法。该组合物包含美沙拉嗪的延迟立即释放和延迟延长释放制剂。
USPTO Abstract
本文描述了用于口服施用美沙拉嗪的药物组合物,以及制备此类药物组合物的方法,以及使用它们的治疗方法。该组合物包含美沙拉嗪的延迟立即释放和延迟延长释放制剂。
Drugs covered by this patent
- Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.